Blog

21 Articles

Abstract image of DNA structure, with linked balls of greens on the left and reds and pinks on the right, forming a spiral net
Research
September 12, 2017 • 2 Min

New Drug for BRCA Carriers with Advanced Cancer

A phase I clinical trial is testing the effectiveness of a platinum-based drug for BRCA carriers with pancreatic, breast, and other cancers.

Illustration of a protein that includes the BRCA2 mutation. The illustration includes spirals in brown, strands in purple, blue directional arrows, and green, yellow, red, and blue circles.
Research
June 27, 2017 • 2 Min

A Maintenance Trial for Patients with BRCA or PALB2 Mutations

A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.

Pancreas cross section embedded in paraffin wax, stained blue and purple, 100x magnification.
Research
January 16, 2017 • 2 Min

Comparing a Standard Chemotherapy With and Without a PARP Inhibitor

A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.

White gloved hands of a lab worker filling a pipette
Research
November 21, 2016 • 4 Min

Immunotherapy Treatments Provide Hope to Pancreatic Cancer Patients

Dr. Robert Vonderheide of the Abramson Cancer Center at the University of Pennsylvania describes immunotherapy trials for pancreatic cancer.

Pasteur pipettes in a circle
Research
November 8, 2016 • 4 Min

BRCA’s Role in Pancreatic Cancer Investigated

The relationship between BRCA and pancreatic cancer, and how that affects treatment, is the focus of clinical trials looking at PARP inhibitors.

Laboratory equipment including pipes, pipettes
Research
October 21, 2016 • 5 Min

Can a Pancreatic Cancer Screening Test Become a Reality?

Dr. Felice Schnoll-Sussman discusses screening options for pancreatic cancer and criteria for people who might want to get screened.

  • 1
  • 2